Comparer des méthodes

	FACT-Colorectal : Évaluation Fonctionnelle des Thérapies contre le Cancer	FACT-Lung : Évaluation fonctionnelle des thérapies anticancéreuses
Domaine	Oncologie	Oncologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	1999	1995
Auteur d'origine	Ward, W. L., et al. (built on Cella, D. F. FACT-G framework)	David F. Cella, Ph.D.
Type	Self-report questionnaire	Self-report questionnaire
Source fondatrice	Ward, W. L., Hahn, E. A., Mo, F., Hernandez, L., Tulsky, D. S., & Cella, D. (1999). Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res, 8(3), 181–195.	Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument for patients with lung cancer. J Clin Oncol, 13(1), 142–153.
Alias	FACT-C	FACT-L
Apparentées	5	5
Résumé	The FACT-Colorectal (FACT-C) is a disease-specific quality-of-life instrument designed for patients with colorectal cancer. It combines the 27-item FACT-G core (general cancer) with a 9-item colorectal-specific subscale addressing bowel function, sexual function, and cancer-related digestive concerns. Validated by Ward et al. in 1999, it is a standard endpoint in colorectal cancer clinical trials and clinical practice monitoring.	The FACT-Lung (FACT-L) is a lung-cancer-specific quality-of-life measure that combines a 27-item general cancer assessment with a 7-item lung cancer subscale. Developed by Cella et al. in 1995, it quantifies physical, emotional, social, and functional well-being specifically relevant to lung cancer patients. It is widely used in clinical trials and practice to assess treatment impact and symptom burden.